LEGN Price Prediction Next Week
Analysis and Insights
To predict the stock price of Legend Biotech (LEGN) for the next trading week, we analyze both fundamental and technical factors.
Fundamental Analysis:
Legend Biotech has shown strong growth driven by its product Carvykti, with Q4 revenue surpassing expectations at $186.5 million. Analysts maintain a bullish outlook, with price targets ranging from $75 to $91. The company aims for operational breakeven by 2025 and profitability by 2026, supported by substantial cash reserves.
Technical Analysis:
The stock shows a neutral RSI of 57.02, indicating it's not overbought or oversold. The MACD is slightly positive, suggesting mild upward momentum. Fibonacci levels indicate resistance at $38 and $39.42, with support at $33.41. Recent price action shows a close at $37.36, up 0.79%.
Conclusion:
Given the strong earnings and bullish analyst sentiment, Legend Biotech's stock is expected to rise. The target price for the next trading week is $39.20, suggesting a Buy recommendation.
LEGN Similar Chart Price Prediction
The price of LEGN is predicted to go up -7.41%, based on the high correlation periods with HAL. The similarity of these two price pattern on the periods is 92.66%.
LEGN
HAL
Down: -7.41%Similarity: 92.66%
LEGN Revenue Forecast
LEGN EPS Forecast
LEGN FAQs
What is LEGN revenue forecast for next quarter？
What is LEGN eps forecast for next quarter？
LEGN Analyst's Forecast
Edward Tenthoff
Piper Sandler
Buy
2024-12-30
Price Target
$78
Upside
+138.02%
Piper Sandler lowered the firm's Carvykti revenue forecast to $290M from $335M in Q4 and to $1.63B from $1.75B in 2025 as Legend Biotech (LEGN) and Johnson & Johnson (JNJ) work to build supply. Carvykti "remains the Gold Standard with demand far outpacing supply," the analyst tells investors in a research note. The firm says Legend and J&J are working to increase supply to 10,000 autologous doses by the end of 2025. Piper reiterates an Overweight rating on Legend Biotech with a $78 price target.
Qize Ding
Redburn Atlantic
Strong Buy
2024-10-08
Price Target
$86
Upside
+78.94%
